Search research articles
Contact Us
Filters
Showing results (121-130 of 143) with videos related to
Page
of 15
Sort By:
Bulletin of the World Health Organization
|
December 19, 2025
Single-step versus conventional injectable artesunate for severe malaria in children: an open label, non-inferiority randomized clinical trial, Democratic Republic of the Congo and United Republic of Tanzania
Samwel Gesase, Marie Onyamboko, Caterina Fanello, et al.
The Lancet. Global Health
|
December 18, 2018
Effect of point-of-care C-reactive protein testing on antibiotic prescription in febrile patients attending primary care in Thailand and Myanmar: an open-label, randomised, controlled trial
Thomas Althaus, Rachel C Greer, Myo Maung Maung Swe, et al.
British Journal of Clinical Pharmacology
|
October 6, 2025
Population pharmacokinetics of artemether-lumefantrine plus amodiaquine in patients with uncomplicated Plasmodium falciparum malaria
Junjie Ding, Richard M Hoglund, Rob W van der Pluijm, et al.
Plos One
|
March 26, 2019
Community engagement, social context and coverage of mass anti-malarial administration: Comparative findings from multi-site research in the Greater Mekong sub-Region
Christopher L Pell, Bipin Adhikari, May Myo Thwin, et al.
The Lancet. Infectious Diseases
|
December 3, 2022
Safety of age-dosed, single low-dose primaquine in children with glucose-6-phosphate dehydrogenase deficiency who are infected with Plasmodium falciparum in Uganda and the Democratic Republic of the Congo: a randomised, double-blind, placebo-controlled, non-inferiority trial
Walter R Taylor, Peter Olupot-Olupot, Marie A Onyamboko, et al.
The Lancet. Infectious Diseases
|
June 10, 2021
Arterolane-piperaquine-mefloquine versus arterolane-piperaquine and artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children: a single-centre, open-label, randomised, non-inferiority trial
Mainga Hamaluba, Rob W van der Pluijm, Joseph Weya, et al.
Science (New York, N.Y.)
|
July 18, 2024
Artemisinin-resistant malaria in Africa demands urgent action
Mehul Dhorda, Akira Kaneko, Ryuichi Komatsu, et al.
Nature Communications
|
December 5, 2024
Population genomics and transcriptomics of Plasmodium falciparum in Cambodia and Vietnam uncover key components of the artemisinin resistance genetic background
Sourav Nayak, Thomas J Peto, Michal Kucharski, et al.
BMC Infectious Diseases
|
April 29, 2017
Cell-free hemoglobin mediated oxidative stress is associated with acute kidney injury and renal replacement therapy in severe falciparum malaria: an observational study
Katherine Plewes, Hugh W F Kingston, Aniruddha Ghose, et al.
Malaria Journal
|
September 10, 2021
Development of weight and age-based dosing of daily primaquine for radical cure of vivax malaria
Walter Robert Taylor, Richard M Hoglund, Pimnara Peerawaranun, et al.
Page
of 15
Search research articles
Search
Showing results (121-130 of 143) with videos related to
Sort By:
Page
of 15
Bulletin of the World Health Organization
|
December 19, 2025
Single-step versus conventional injectable artesunate for severe malaria in children: an open label, non-inferiority randomized clinical trial, Democratic Republic of the Congo and United Republic of Tanzania
Samwel Gesase, Marie Onyamboko, Caterina Fanello, et al.
The Lancet. Global Health
|
December 18, 2018
Effect of point-of-care C-reactive protein testing on antibiotic prescription in febrile patients attending primary care in Thailand and Myanmar: an open-label, randomised, controlled trial
Thomas Althaus, Rachel C Greer, Myo Maung Maung Swe, et al.
British Journal of Clinical Pharmacology
|
October 6, 2025
Population pharmacokinetics of artemether-lumefantrine plus amodiaquine in patients with uncomplicated Plasmodium falciparum malaria
Junjie Ding, Richard M Hoglund, Rob W van der Pluijm, et al.
Plos One
|
March 26, 2019
Community engagement, social context and coverage of mass anti-malarial administration: Comparative findings from multi-site research in the Greater Mekong sub-Region
Christopher L Pell, Bipin Adhikari, May Myo Thwin, et al.
The Lancet. Infectious Diseases
|
December 3, 2022
Safety of age-dosed, single low-dose primaquine in children with glucose-6-phosphate dehydrogenase deficiency who are infected with Plasmodium falciparum in Uganda and the Democratic Republic of the Congo: a randomised, double-blind, placebo-controlled, non-inferiority trial
Walter R Taylor, Peter Olupot-Olupot, Marie A Onyamboko, et al.
The Lancet. Infectious Diseases
|
June 10, 2021
Arterolane-piperaquine-mefloquine versus arterolane-piperaquine and artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children: a single-centre, open-label, randomised, non-inferiority trial
Mainga Hamaluba, Rob W van der Pluijm, Joseph Weya, et al.
Science (New York, N.Y.)
|
July 18, 2024
Artemisinin-resistant malaria in Africa demands urgent action
Mehul Dhorda, Akira Kaneko, Ryuichi Komatsu, et al.
Nature Communications
|
December 5, 2024
Population genomics and transcriptomics of Plasmodium falciparum in Cambodia and Vietnam uncover key components of the artemisinin resistance genetic background
Sourav Nayak, Thomas J Peto, Michal Kucharski, et al.
BMC Infectious Diseases
|
April 29, 2017
Cell-free hemoglobin mediated oxidative stress is associated with acute kidney injury and renal replacement therapy in severe falciparum malaria: an observational study
Katherine Plewes, Hugh W F Kingston, Aniruddha Ghose, et al.
Malaria Journal
|
September 10, 2021
Development of weight and age-based dosing of daily primaquine for radical cure of vivax malaria
Walter Robert Taylor, Richard M Hoglund, Pimnara Peerawaranun, et al.
Page
of 15